ENDOLAP RESECTOSCOPE ROLLER ELECTRODE

K974515 · Endolap, Inc. · FAS · Dec 22, 1997 · Gastroenterology, Urology

Device Facts

Record IDK974515
Device NameENDOLAP RESECTOSCOPE ROLLER ELECTRODE
ApplicantEndolap, Inc.
Product CodeFAS · Gastroenterology, Urology
Decision DateDec 22, 1997
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 876.4300
Device ClassClass 2
AttributesTherapeutic

Intended Use

The Endolap Resectoscope Roller Electrode device is a monopolar electrode designed to deliver radio frequency energy that is supplied by an electrical generator cleared for medical use. The Endolap Resectoscope roller electrode device is indicated for ablation and coagulation of the soft tissue and is intended for use with compatible resectoscopes.

Device Story

Monopolar electrode; delivers radio frequency (RF) energy from external cleared electrosurgical generator to soft tissue. Used for ablation and coagulation during endoscopic procedures. Operated by physicians in clinical/surgical settings using compatible resectoscopes. Output is thermal energy for tissue modification; assists in surgical hemostasis and tissue removal.

Clinical Evidence

Bench testing only.

Technological Characteristics

Monopolar electrosurgical electrode; metallic construction; compatible with standard RF generators; designed for endoscopic resectoscope integration.

Indications for Use

Indicated for ablation and coagulation of soft tissue in patients requiring electrosurgical intervention; intended for use with compatible resectoscopes by trained clinicians.

Regulatory Classification

Identification

An endoscopic electrosurgical unit and accessories is a device used to perform electrosurgical procedures through an endoscope. This generic type of device includes the electrosurgical generator, patient plate, electric biopsy forceps, electrode, flexible snare, electrosurgical alarm system, electrosurgical power supply unit, electrical clamp, self-opening rigid snare, flexible suction coagulator electrode, patient return wristlet, contact jelly, adaptor to the cord for transurethral surgical instruments, the electric cord for transurethral surgical instruments, and the transurethral desiccator.

Related Devices

Submission Summary (Full Text)

{0} DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 DEC 22 1997 Mr. L. A. Tony Gilstrap Chief Operating Officer ENDOlap™, Inc. 3012 Mercy Drive Orlando, Florida 32808 Re: K974515 ENDOlap™ Resectoscope Roller Electrode Dated: November 15, 1997 Received: December 2, 1997 Regulatory class: II 21 CFR §876.4300/Product code: 78 FAS 21 CFR §876.1500/Product code: 78 FDC Dear Mr. Gilstrap: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsmamain.html". Sincerely yours, ![img-0.jpeg](img-0.jpeg) Enclosure {1} Page ___ of ___ 510(k) NUMBER (IF KNOWN): K974515 DEVICE NAME: Resctoscope Roller electrode INDICATIONS FOR USE: The Endolap Resectoscope Roller Electrode device is a monopolar electrode designed to deliver radio frequency energy that is supplied by an electrical generator cleared for medical use. The Endolap Resectoscope roller electrode device is indicated for ablation and coagulation of the soft tissue and is intended for use with compatible resectoscopes. (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED.) Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use ☑ OR Over-The-Counter-Use (Per 21 CFR 801.109) (Optional Format 1-2-96) (Division Sign-Off) Division of Reproductive, Abdominal, ENT. and Radiological Devices 510(k) Number K974515
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...